Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D051381:Rats
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines